For Ampersand, the Avid deal closely follows the acquisition of Nektar Therapeutics’ commercial-scale manufacturing facility ...

For Ampersand, the Avid deal closely follows the acquisition of Nektar Therapeutics’ commercial-scale manufacturing facility ...

The ability to genetically engineer plants is largely thanks to a microscopic helper: a bacterium called Agrobacterium ...

Cytek will host a conference call to discuss its third quarter 2024 financial results on Tuesday, November 5, 2024, at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. A webcast of the conference call ...

High-throughput screening (HTS) enables the rapid testing of numerous compounds against biological targets. By automating and ...

Cytek’s products are for research use only and not for use in diagnostic procedures (other than Cytek’s Northern Lights-CLC system and certain reagents, which are available for clinical use only in ...

FREMONT, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the following ...

Government Regulations and Environmental Concerns: Governments around the world are imposing stricter environmental ...

Illumina, a United States-headquartered company specializing in DNA sequencing and array-based technologies, is showcasing ...